Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/445

Authors: CANNISTRA SA
Citation: Sa. Cannistra, PACLITAXEL IN OVARIAN-CANCER - HOW CAN WE MAKE IT BETTER, Journal of clinical oncology, 12(9), 1994, pp. 1743-1744

Authors: PINEDO HM VANGROENINGEN CJ
Citation: Hm. Pinedo et Cj. Vangroeningen, VINORELBINE - A HORSE OF A DIFFERENT COLOR, Journal of clinical oncology, 12(9), 1994, pp. 1745-1747

Authors: THIGPEN JT BLESSING JA BALL H HUMMEL SJ BARRETT RJ
Citation: Jt. Thigpen et al., PHASE-II TRIAL OF PACLITAXEL IN PATIENTS WITH PROGRESSIVE OVARIAN-CARCINOMA AFTER PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(9), 1994, pp. 1748-1753

Authors: ROWINSKY EK NOE DA TRUMP DL WINER EP LUCAS VS WARGIN WA HOHNEKER JA LUBEJKO B SARTORIUS SE ETTINGER DS DONEHOWER RC
Citation: Ek. Rowinsky et al., PHARMACOKINETIC, BIOAVAILABILITY, AND FEASIBILITY STUDY OF ORAL VINORELBINE IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 12(9), 1994, pp. 1754-1763

Authors: SPIELMANN M DORVAL T TURPIN F ANTOINE E JOUVE M MAYLEVIN F LACOMBE D ROUESSE J POUILLART P TURSZ T MERLE S
Citation: M. Spielmann et al., PHASE-II TRIAL OF VINORELBINE DOXORUBICIN AS FIRST-LINE THERAPY OF ADVANCED BREAST-CANCER, Journal of clinical oncology, 12(9), 1994, pp. 1764-1770

Authors: WISHART GC BISSETT D PAUL J JODRELL D HARNETT A HABESHAW T KERR DJ MACHAM MA SOUKOP M LEONARD RCF KNEPIL J KAYE SB
Citation: Gc. Wishart et al., QUINIDINE AS A RESISTANCE MODULATOR OF EPIRUBICIN IN ADVANCED BREAST-CANCER - MATURE RESULTS OF A PLACEBO-CONTROLLED RANDOMIZED TRIAL, Journal of clinical oncology, 12(9), 1994, pp. 1771-1777

Authors: OMNEPONTEN M HOLMBERG L SJODEN PO
Citation: M. Omneponten et al., PSYCHOSOCIAL ADJUSTMENT AMONG WOMEN WITH BREAST-CANCER STAGE-I AND STAGE-II - 6-YEAR FOLLOW-UP OF CONSECUTIVE PATIENTS, Journal of clinical oncology, 12(9), 1994, pp. 1778-1782

Authors: JOHNSON TP FORD L WARNECKE RB NAYFIELD SG KALUZNY A CUTTER G GILLINGS D SONDIK E OZER H
Citation: Tp. Johnson et al., EFFECT OF A NATIONAL-CANCER-INSTITUTE CLINICAL-ALERT ON BREAST-CANCERPRACTICE PATTERNS, Journal of clinical oncology, 12(9), 1994, pp. 1783-1788

Authors: CHLEBOWSKI RT LILLINGTON LM
Citation: Rt. Chlebowski et Lm. Lillington, A DECADE OF BREAST-CANCER CLINICAL INVESTIGATION - RESULTS AS REPORTED IN THE PROGRAM PROCEEDINGS OF THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY/, Journal of clinical oncology, 12(9), 1994, pp. 1789-1795

Authors: TAYLOR KM FELDSTEIN ML SKEEL RT PANDYA KJ NG P CARBONE PP
Citation: Km. Taylor et al., FUNDAMENTAL DILEMMAS OF THE RANDOMIZED CLINICAL-TRIAL PROCESS - RESULTS OF A SURVEY OF THE 1,737 EASTERN-COOPERATIVE-ONCOLOGY-GROUP INVESTIGATORS, Journal of clinical oncology, 12(9), 1994, pp. 1796-1805

Authors: SOUHAMI RL RUDD R DEELVIRA MCR JAMES L GOWER N HARPER PG TOBIAS JS PARTRIDGE MR DAVISON AG TRASK C SPIRO SG
Citation: Rl. Souhami et al., RANDOMIZED TRIAL COMPARING WEEKLY VERSUS 3-WEEK CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL, Journal of clinical oncology, 12(9), 1994, pp. 1806-1813

Authors: HAZUKA MB CROWLEY JJ BUNN PA OROURKE M BRAUN TJ LIVINGSTON RB
Citation: Mb. Hazuka et al., DAILY LOW-DOSE CISPLATIN PLUS CONCURRENT HIGH-DOSE THORACIC IRRADIATION IN LOCALLY ADVANCED UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(9), 1994, pp. 1814-1820

Authors: ANDERSON H LUND B BACH F THATCHER N WALLING J HANSEN HH
Citation: H. Anderson et al., SINGLE-AGENT ACTIVITY OF WEEKLY GEMCITABINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 12(9), 1994, pp. 1821-1826

Authors: PASSLICK B IZBICKI JR KUBUSCHOK B NATHRATH W THETTER O PICHLMEIER U SCHWEIBERER L RIETHMULLER G PANTEL K
Citation: B. Passlick et al., IMMUNOHISTOCHEMICAL ASSESSMENT OF INDIVIDUAL TUMOR-CELLS IN LYMPH-NODES OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(9), 1994, pp. 1827-1832

Authors: MASUDA N FUKUOKA M KUDOH S MATSUI K KUSUNOKI Y TAKADA M NAKAGAWA K HIRASHIMA T TSUKADA H YANA T YOSHIKAWA A KUBO A MATSUURA E NITTA T TAKIFUJI N TERAKAWA K NEGORO S
Citation: N. Masuda et al., PHASE-I AND PHARMACOLOGICAL STUDY OF IRINOTECAN AND ETOPOSIDE WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR ADVANCED LUNG-CANCER, Journal of clinical oncology, 12(9), 1994, pp. 1833-1841

Authors: ORNADEL D SOUHAMI RL WHELAN J NOOY M DEELVIRA CR PRINGLE J LEWIS I STEWARD WP GEORGE R BRIDGEWATER J WIERZBICKI R CRAFT AW
Citation: D. Ornadel et al., DOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA - PHASE-II TRIAL OF THE EUROPEAN-OSTEOSARCOMA-INTERGROUP, Journal of clinical oncology, 12(9), 1994, pp. 1842-1848

Authors: WARD WG MIKAELIAN K DOREY F MIRRA JM SASSOON A HOLMES EC EILBER FR ECKARDT JJ
Citation: Wg. Ward et al., PULMONARY METASTASES OF STAGE IIB EXTREMITY OSTEOSARCOMA AND SUBSEQUENT PULMONARY METASTASES, Journal of clinical oncology, 12(9), 1994, pp. 1849-1858

Authors: HEISS MM MEMPEL W DELANOFF C JAUCH KW GABKA C MEMPEL M DIETERICH HJ EISSNER HJ SCHILDBERG FW
Citation: Mm. Heiss et al., BLOOD TRANSFUSION-MODULATED TUMOR RECURRENCE - FIRST RESULTS OF A RANDOMIZED STUDY OF AUTOLOGOUS VERSUS ALLOGENEIC BLOOD-TRANSFUSION IN COLORECTAL-CANCER SURGERY, Journal of clinical oncology, 12(9), 1994, pp. 1859-1867

Authors: HUSSAIN M WOLF M MARSHALL E CRAWFORD ED EISENBERGER M
Citation: M. Hussain et al., EFFECTS OF CONTINUED ANDROGEN-DEPRIVATION THERAPY AND OTHER PROGNOSTIC FACTORS ON RESPONSE AND SURVIVAL IN PHASE-II CHEMOTHERAPY TRIALS FORHORMONE-REFRACTORY PROSTATE-CANCER - A SOUTHWEST-ONCOLOGY-GROUP REPORT, Journal of clinical oncology, 12(9), 1994, pp. 1868-1875

Authors: LEYVRAZ S PASCHE P BAUER J BERNASCONI S MONNIER P
Citation: S. Leyvraz et al., RAPIDLY ALTERNATING CHEMOTHERAPY AND HYPERFRACTIONATED RADIOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED HEAD-AND-NECK-CARCINOMA - 4-YEAR RESULTS OF A PHASE-I II STUDY/, Journal of clinical oncology, 12(9), 1994, pp. 1876-1885

Authors: WATLING CJ LEE DH MACDONALD DR CAIRNCROSS JG
Citation: Cj. Watling et al., CORTICOSTEROID-INDUCED MAGNETIC-RESONANCE-IMAGING CHANGES IN PATIENTSWITH RECURRENT MALIGNANT GLIOMA, Journal of clinical oncology, 12(9), 1994, pp. 1886-1889

Authors: ADKINS DR SALZMAN D BOLDT D KUHN J IRVIN R ROODMAN GD LYONS R SMITH L FREYTES CO LEMAISTRE CF
Citation: Dr. Adkins et al., PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA, Journal of clinical oncology, 12(9), 1994, pp. 1890-1901

Authors: BUDMAN DR IGWEMEZIE LN KAUL S BEHR J LICHTMAN S SCHULMAN P VINCIGUERRA V ALLEN SL KOLITZ J HOCK K ONEILL K SCHACTER L BARBHAIYA RH
Citation: Dr. Budman et al., PHASE-I EVALUATION OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE, GIVEN AS A 5-MINUTE INFUSION ON DAY-1, DAY-3, AND DAY-5 IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 12(9), 1994, pp. 1902-1909

Authors: MILES SA WANG HJ ELASHOFF R MITSUYASU RT
Citation: Sa. Miles et al., IMPROVED SURVIVAL FOR PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Journal of clinical oncology, 12(9), 1994, pp. 1910-1916

Authors: GORDON B SPADINGER A HODGES E RUBY E STANLEY R COCCIA P
Citation: B. Gordon et al., EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON ORAL MUCOSITIS AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Journal of clinical oncology, 12(9), 1994, pp. 1917-1922
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>